Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of October 26, 2026, ARTL trades at $2.40 with a market cap of $1.40M and a P/E ratio of 0.00. ARTL moved -6.67% today. Year to date, ARTL is -92.26%; over the trailing twelve months it is -97.23%. Its 52-week range spans $2.48 to $772.20. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ARTL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.40 |
| Market Cap | $1.40M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $772.20 |
| 52-Week Low | $2.48 |
| Volume | 104.54K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-9.83M |
| Gross Margin | 0.00% |
ARTL analyst coverage data. Average price target: $0.00.